AI assistant
Cigna Group — Director's Dealing 2024
May 16, 2024
29918_dirs_2024-05-16_6c25e904-53cf-4426-8787-4769574d3452.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cigna Group (CI)
CIK: 0001739940
Period of Report: 2024-05-14
Reporting Person: Agoglia Hoeltzel Mary T (SVP Tax & Chief Acct. Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-14 | Common Stock, $.01 Par Value | M | 5946.0000 | $120.8950 | Acquired | 8540.7380 | Direct |
| 2024-05-14 | Common Stock, $.01 Par Value | S | 5946.0000 | $348.7133 | Disposed | 2594.7380 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-05-14 | Employee Stock Option (Right to Buy) | $120.8950 | M | 5946.0000 | Disposed | 2025-02-25 | Common Stock, $.01 Par Value (5946.0000) | Direct |
Footnotes
F1: Balance includes 8.414 shares of common stock received from her participation in a dividend reinvestment plan.
F2: Represents the weighted average price of the shares sold. The prices actually received ranged from $348.68 to $349.01 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
F3: This option was granted on February 25, 2015. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.